A.R.T. Advisors’s Amedisys AMED Stock Holding History

A.R.T. Advisors’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-11,928	Closed	-$1.4M	–	1285
2018 Q4	$1.4M	Buy	+11,928	New	+$1.41M	0.09%	336
2018 Q1	–	Sell	-4,231	Closed	-$223K	–	1475
2017 Q4	$223K	Buy	+4,231	New	+$223K	0.01%	1128
2016 Q2	–	Sell	-50,626	Closed	-$2.45M	–	1337
2016 Q1	$2.45M	Buy	50,626 +22,100	+77%	+$853K	0.11%	266
2015 Q4	$1.12M	Buy	+28,526	New	+$1.14M	0.05%	512
2015 Q2	–	Sell	-13,438	Closed	-$359K	–	1456
2015 Q1	$359K	Buy	+13,438	New	+$379K	0.01%	1040
2014 Q3	–	Sell	-20,314	Closed	-$340K	–	1291
2014 Q2	$340K	Buy	+20,314	New	+$288K	0.02%	944

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

A.R.T. Advisors's AMED Position: Q1 2019 in Review

A.R.T. Advisors sold out of Amedisys (AMED) in Q1 2019, closing a stake of 11,928 shares — an estimated $1.4M sold.

A.R.T. Advisors first reported a position in AMED in Q2 2014 and held it in 6 quarters. The position peaked at $2.45M in Q1 2016. 317 funds tracked by Wall St. Rank hold AMED as of Q1 2019.

A.R.T. Advisors reported no remaining Amedisys position as of Q1 2019 after selling out during the quarter.
A.R.T. Advisors sold 11,928 Amedisys shares in Q1 2019, an estimated $1.4M.
A.R.T. Advisors first reported a position in Amedisys in Q2 2014 and held it in 6 quarters.
A.R.T. Advisors's Amedisys position peaked at $2.45M in Q1 2016.
317 funds tracked by Wall St. Rank held Amedisys as of Q1 2019.

Based on A.R.T. Advisors's 13F filing for Q1 2019, filed 15 May 2019.